Kopran Limited KOPRAN.NS Stock
Kopran Limited Price Chart
Kopran Limited KOPRAN.NS Financial and Trading Overview
| Kopran Limited stock price | 232.3 INR |
| Previous Close | 182.85 INR |
| Open | 183.2 INR |
| Bid | 183.7 INR x 0 |
| Ask | 183.95 INR x 0 |
| Day's Range | 180.75 - 186.5 INR |
| 52 Week Range | 96 - 219.4 INR |
| Volume | 249.51K INR |
| Avg. Volume | 352.25K INR |
| Market Cap | 8.86B INR |
| Beta (5Y Monthly) | 0.67089 |
| PE Ratio (TTM) | 32.75401 |
| EPS (TTM) | 10.55 INR |
| Forward Dividend & Yield | 3 (1.65%) |
| Ex-Dividend Date | August 5, 2022 |
| 1y Target Est | N/A |
KOPRAN.NS Valuation Measures
| Enterprise Value | 9.43B INR |
| Trailing P/E | 32.75401 |
| Forward P/E | 32.407406 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.607787 |
| Price/Book (mrq) | 2.0135663 |
| Enterprise Value/Revenue | 1.712 |
| Enterprise Value/EBITDA | 16.474 |
Trading Information
Kopran Limited Stock Price History
| Beta (5Y Monthly) | 0.67089 |
| 52-Week Change | -7.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 219.4 INR |
| 52 Week Low | 96 INR |
| 50-Day Moving Average | 153.09 INR |
| 200-Day Moving Average | 147.41 INR |
KOPRAN.NS Share Statistics
| Avg. Volume (3 month) | 352.25K INR |
| Avg. Daily Volume (10-Days) | 674.17K INR |
| Shares Outstanding | 48.21M |
| Float | 23.7M |
| Short Ratio | N/A |
| % Held by Insiders | 51.33% |
| % Held by Institutions | 0.0030% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 3 |
| Trailing Annual Dividend Yield | 1.64% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.53099996 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 4.94% |
| Operating Margin (ttm) | 8.08% |
| Gross Margin | 34.92% |
| EBITDA Margin | 10.39% |
Management Effectiveness
| Return on Assets (ttm) | 4.41% |
| Return on Equity (ttm) | 6.29% |
Income Statement
| Revenue (ttm) | 5.51B INR |
| Revenue Per Share (ttm) | 114.31 INR |
| Quarterly Revenue Growth (yoy) | 4.20% |
| Gross Profit (ttm) | 1.92B INR |
| EBITDA | 572.57M INR |
| Net Income Avi to Common (ttm) | 272.33M INR |
| Diluted EPS (ttm) | 5.61 |
| Quarterly Earnings Growth (yoy) | -54.10% |
Balance Sheet
| Total Cash (mrq) | 125.8M INR |
| Total Cash Per Share (mrq) | 2.61 INR |
| Total Debt (mrq) | 752.38M INR |
| Total Debt/Equity (mrq) | 17.13 INR |
| Current Ratio (mrq) | 2.255 |
| Book Value Per Share (mrq) | 91.256 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 340.23M INR |
| Levered Free Cash Flow (ttm) | 220.58M INR |
Profile of Kopran Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | Parijat House |
| ZIP | 400018 |
| Phone | 91 22 4366 1111 |
| Website | https://www.kopran.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.
Q&A For Kopran Limited Stock
What is a current KOPRAN.NS stock price?
Kopran Limited KOPRAN.NS stock price today per share is 232.3 INR.
How to purchase Kopran Limited stock?
You can buy KOPRAN.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kopran Limited?
The stock symbol or ticker of Kopran Limited is KOPRAN.NS.
Which industry does the Kopran Limited company belong to?
The Kopran Limited industry is Drug Manufacturers-General.
How many shares does Kopran Limited have in circulation?
The max supply of Kopran Limited shares is 48.21M.
What is Kopran Limited Price to Earnings Ratio (PE Ratio)?
Kopran Limited PE Ratio is 22.01895700 now.
What was Kopran Limited earnings per share over the trailing 12 months (TTM)?
Kopran Limited EPS is 10.55 INR over the trailing 12 months.
Which sector does the Kopran Limited company belong to?
The Kopran Limited sector is Healthcare.